K858產品是K858 is a selective ATP-uncompetitive mitotic kinesin Eg5 inhibitor (IC?? = 1.3 μM) and an antitumor agent. Induces cell death in cancer cells, blocks centrosome separation, activates the spindle checkpoint, and induces mitotic arrest in cells accompanied by the formation of monopolar spindles.